Cite
LncRNA SLC25A21-AS1 increases the chemosensitivity and inhibits the progression of ovarian cancer by upregulating the expression of KCNK4.
MLA
Huang, Ke, et al. “LncRNA SLC25A21-AS1 Increases the Chemosensitivity and Inhibits the Progression of Ovarian Cancer by Upregulating the Expression of KCNK4.” Functional & Integrative Genomics, vol. 23, no. 2, Mar. 2023, p. 110. EBSCOhost, https://doi.org/10.1007/s10142-023-01035-x.
APA
Huang, K., Chen, X., Geng, Z., Xiong, X., Cong, Y., Pan, X., Liu, S., Ge, L., Xu, J., & Jia, X. (2023). LncRNA SLC25A21-AS1 increases the chemosensitivity and inhibits the progression of ovarian cancer by upregulating the expression of KCNK4. Functional & Integrative Genomics, 23(2), 110. https://doi.org/10.1007/s10142-023-01035-x
Chicago
Huang, Ke, Xiyi Chen, Zhe Geng, Xueyou Xiong, Yu Cong, Xinxing Pan, Siyu Liu, Lili Ge, Juan Xu, and Xuemei Jia. 2023. “LncRNA SLC25A21-AS1 Increases the Chemosensitivity and Inhibits the Progression of Ovarian Cancer by Upregulating the Expression of KCNK4.” Functional & Integrative Genomics 23 (2): 110. doi:10.1007/s10142-023-01035-x.